Sale!

Lung Cancer Panel 3 EGFRALK1ROS1MET Test Cost

Name: Lung Cancer Panel 3 EGFRALK1ROS1MET Test Cost
SKU: TEST-768
Price: 6600 AED
Availability: InStock

Original price was: 8,000 د.إ.Current price is: 6,600 د.إ.

-18%

The “Lung Cancer Panel 3 EGFR/ALK1/ROS1/MET Test” is a comprehensive molecular diagnostic test offered by DNA Labs UAE, designed to identify specific genetic mutations associated with lung cancer. This panel focuses on four key genes: EGFR, ALK1, ROS1, and MET, which are known to play significant roles in the development and progression of lung cancer. By analyzing these genes, the test can help determine the most effective treatment options for patients, including targeted therapies that can significantly improve outcomes.

The cost of the Lung Cancer Panel 3 test is 6600 AED. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test involves a detailed examination of the patient’s DNA sample to identify mutations in the specified genes. This information is crucial for oncologists to tailor treatment plans to the genetic profile of the tumor, thereby offering a personalized approach to lung cancer treatment. The results from this test can provide valuable insights into the prognosis of the disease and guide decisions regarding the use of specific drugs or treatment regimens, making it a vital tool in the management of lung cancer.

Description

Lung Cancer Panel 3 EGFRALK1ROS1MET Test

Test Name: Lung Cancer Panel 3 EGFRALK1ROS1MET Test

Components: Paraffin embedded tissue blocks

Price: 6600.0 AED

Sample Condition: Tumor tissue

Report Delivery: 5-7 days

Method: FISH, Sanger Sequencing

Test type: Genetics

Doctor: Oncology

Test Department:

Pre Test Information: Lung Cancer Panel 3 EGFRALK1ROS1MET Test can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details:

The Lung Cancer Panel 3 is a diagnostic test that looks for mutations in four genes that are commonly associated with lung cancer: EGFR, ALK1, ROS1, and MET. These genes play a role in the growth and proliferation of lung cancer cells.

EGFR (epidermal growth factor receptor) is a protein that is involved in cell growth and division. Mutations in the EGFR gene can lead to uncontrolled cell growth and the development of cancer.

ALK1 (anaplastic lymphoma kinase 1) is a gene that produces a protein involved in cell signaling. Mutations in this gene have been linked to the development of non-small cell lung cancer.

ROS1 (c-ros oncogene 1) is a gene that produces a protein involved in cell growth and division. Mutations in this gene have been found in a small percentage of lung cancer cases.

MET (mesenchymal-epithelial transition factor) is a gene that produces a protein involved in cell growth and survival. Mutations in this gene have been linked to the development of various types of cancer, including lung cancer.

By analyzing these four genes, the Lung Cancer Panel 3 can provide valuable information about the genetic makeup of a patient’s lung cancer. This information can be used to guide treatment decisions and improve outcomes for patients with lung cancer.

Test Name	Lung Cancer Panel 3 EGFRALK1ROS1MET Test
Components	Paraffin embedded tissue blocks
Price	6600.0 AED
Sample Condition	Tumor tissue
Report Delivery	5-7 days
Method	FISH,Sanger Sequencing
Test type	Genetics
Doctor	Oncology
Test Department:
Pre Test Information	Lung Cancer Panel 3 EGFR,ALK1,ROS1,MET] can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details	The Lung Cancer Panel 3 is a diagnostic test that looks for mutations in four genes that are commonly associated with lung cancer: EGFR, ALK1, ROS1, and MET. These genes play a role in the growth and proliferation of lung cancer cells. EGFR (epidermal growth factor receptor) is a protein that is involved in cell growth and division. Mutations in the EGFR gene can lead to uncontrolled cell growth and the development of cancer. ALK1 (anaplastic lymphoma kinase 1) is a gene that produces a protein involved in cell signaling. Mutations in this gene have been linked to the development of non-small cell lung cancer. ROS1 (c-ros oncogene 1) is a gene that produces a protein involved in cell growth and division. Mutations in this gene have been found in a small percentage of lung cancer cases. MET (mesenchymal-epithelial transition factor) is a gene that produces a protein involved in cell growth and survival. Mutations in this gene have been linked to the development of various types of cancer, including lung cancer. By analyzing these four genes, the Lung Cancer Panel 3 can provide valuable information about the genetic makeup of a patient’s lung cancer. This information can be used to guide treatment decisions and improve outcomes for patients with lung cancer.